You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

CHIROCAINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Chirocaine, and what generic alternatives are available?

Chirocaine is a drug marketed by Purdue Pharma Lp and is included in one NDA.

The generic ingredient in CHIROCAINE is levobupivacaine hydrochloride. Additional details are available on the levobupivacaine hydrochloride profile page.

Drug patent expirations by year for CHIROCAINE
Recent Clinical Trials for CHIROCAINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Chinese University of Hong KongPhase 4
National Taiwan University HospitalN/A
Centre Hospitalier Universitaire Saint PierrePhase 4

See all CHIROCAINE clinical trials

US Patents and Regulatory Information for CHIROCAINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Purdue Pharma Lp CHIROCAINE levobupivacaine hydrochloride INJECTABLE;INJECTION 020997-001 Aug 5, 1999 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Purdue Pharma Lp CHIROCAINE levobupivacaine hydrochloride INJECTABLE;INJECTION 020997-002 Aug 5, 1999 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Purdue Pharma Lp CHIROCAINE levobupivacaine hydrochloride INJECTABLE;INJECTION 020997-003 Aug 5, 1999 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for CHIROCAINE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Purdue Pharma Lp CHIROCAINE levobupivacaine hydrochloride INJECTABLE;INJECTION 020997-001 Aug 5, 1999 ⤷  Try a Trial ⤷  Try a Trial
Purdue Pharma Lp CHIROCAINE levobupivacaine hydrochloride INJECTABLE;INJECTION 020997-002 Aug 5, 1999 ⤷  Try a Trial ⤷  Try a Trial
Purdue Pharma Lp CHIROCAINE levobupivacaine hydrochloride INJECTABLE;INJECTION 020997-003 Aug 5, 1999 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for CHIROCAINE

See the table below for patents covering CHIROCAINE around the world.

Country Patent Number Title Estimated Expiration
Canada 2173207 LEVOBUPIVACAINE ET SON UTILISATION COMME ANESTHESIE CHEZ LESPATIENTS AYANT OU ETANT DISPOSES A DES CONTRACTILITES MYOCARDIQUES DIMINUES (LEVOBUPIVACAINE AND ITS USE AS AN ANAESTHETIC IN PATIENTS HAVING OR DISPOSED TO DEPRESSED MYOCARDIAL CONTRACTILITY) ⤷  Try a Trial
World Intellectual Property Organization (WIPO) 9510277 ⤷  Try a Trial
China 1184426 ⤷  Try a Trial
Australia 7859394 ⤷  Try a Trial
Spain 2105766 ⤷  Try a Trial
European Patent Office 0723444 LEVOBUPIVACAINE UTILISEE DANS LE TRAITEMENT DE LA DOULEUR CHRONIQUE (LEVOBUPIVACAINE USEFUL FOR MANAGING CHRONIC PAIN) ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.